Literature DB >> 35891741

Evaluation of in vivo Lethality and in vitro Cytotoxic Effect of Odontobuthus bidentatus Scorpion Venom.

Z Salehi-Najafabadi1, H R Goudarzi1, M Sajadi2.   

Abstract

The results of numerous studies have revealed that some deadly scorpion venoms are composed of various bioactive molecules that have significant cytotoxic effects on cancer cells. In this study, the in vivo lethality and cytotoxic effect of Odontobuthus bidentatus venom were evaluated in different cancer cell lines. Through MTT assay, the cytotoxic effects of O. bidentatus scorpion venom were analyzed on the MCF-7, A549, AGS, HepG2, and Ht-29 cancer cell lines and Hu02 normal cells. To this end, six venom fractions were obtained through a Sephadex G-50 column, and the cytotoxic effects of isolated fractions were evaluated on A549 lung cancer cells. The median lethal dose of O. bidentatus scorpion venom was determined at 0.73 mg/kg by intravenous administration of different venom doses in male BALB/c mice according to the Spearman-Karber method. The O. bidentatus scorpion whole venom had a significant cytotoxic effect on MCF-7, A549, and AGS cells. The treatment of A549 cells with various concentrations of fraction F1 showed that this fraction significantly induced growth inhibitory effect on the cells in a dose-dependent manner, compared to untreated cells.

Entities:  

Keywords:  Cancer cells; Cytotoxic effects; LD50; Odontobuthus bidentatus venom

Mesh:

Substances:

Year:  2022        PMID: 35891741      PMCID: PMC9288595          DOI: 10.22092/ARI.2021.353302.1595

Source DB:  PubMed          Journal:  Arch Razi Inst        ISSN: 0365-3439


  19 in total

1.  Cancer prevention from the perspective of global cancer burden patterns.

Authors:  Hiroki Nagai; Young Hak Kim
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

Review 2.  Scorpion venoms as a potential source of novel cancer therapeutic compounds.

Authors:  Jian Ding; Pei-Jou Chua; Boon-Huat Bay; P Gopalakrishnakone
Journal:  Exp Biol Med (Maywood)       Date:  2014-03-05

Review 3.  Arthropod venoms and cancer.

Authors:  Tiago Elias Heinen; Ana Beatriz Gorini da Veiga
Journal:  Toxicon       Date:  2011-01-12       Impact factor: 3.033

4.  In vitro and in vivo antitumor effects of the Egyptian scorpion Androctonus amoreuxi venom in an Ehrlich ascites tumor model.

Authors:  Mohamed L Salem; Nahla M Shoukry; Wafaa K Teleb; Mohamed M Abdel-Daim; Mohamed A Abdel-Rahman
Journal:  Springerplus       Date:  2016-05-10

5.  Scorpion (Androctonus bicolor) venom exhibits cytotoxicity and induces cell cycle arrest and apoptosis in breast and colorectal cancer cell lines.

Authors:  Abdulrahman K Al-Asmari; Anvarbatcha Riyasdeen; Rajamohamed Abbasmanthiri; Mohammed Arshaduddin; Fahad Ali Al-Harthi
Journal:  Indian J Pharmacol       Date:  2016 Sep-Oct       Impact factor: 1.200

6.  Scorpion venoms in gastric cancer.

Authors:  Xiao-Ying Zhang; Pei-Ying Zhang
Journal:  Oncol Lett       Date:  2016-09-14       Impact factor: 2.967

Review 7.  Scorpion and spider venoms in cancer treatment: state of the art, challenges, and perspectives.

Authors:  Catarina Rapôso
Journal:  J Clin Transl Res       Date:  2017-05-24

8.  Assessment of the evolution of cancer treatment therapies.

Authors:  Manuel Arruebo; Nuria Vilaboa; Berta Sáez-Gutierrez; Julio Lambea; Alejandro Tres; Mónica Valladares; Africa González-Fernández
Journal:  Cancers (Basel)       Date:  2011-08-12       Impact factor: 6.639

9.  Rhopalurus junceus scorpion venom induces antitumor effect in vitro and in vivo against a murine mammary adenocarcinoma model.

Authors:  Alexis Díaz-García; Jenny Laura Ruiz-Fuentes; Yahima Frión-Herrera; Arianna Yglesias-Rivera; Yanelis Riquenez Garlobo; Hermis Rodríguez Sánchez; Juan C Rodríguez Aurrecochea; Ledys X López Fuentes
Journal:  Iran J Basic Med Sci       Date:  2019-07       Impact factor: 2.699

Review 10.  Scorpion Venom-Toxins that Aid in Drug Development: A Review.

Authors:  Arijit Ghosh; Rini Roy; Monoswini Nandi; Ashis Mukhopadhyay
Journal:  Int J Pept Res Ther       Date:  2018-06-05       Impact factor: 1.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.